Li Li

Dr. Li Li


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
QXQianhua Xu
Qianhua Xu
YXYunlong Xiang
Yunlong Xiang
QWQiujun Wang
Qiujun Wang
LWLeyun Wang
Leyun Wang
JBJulie Brind’aMour
Julie Brind’aMour
WXWei Xie
Wei Xie

20 July 2008 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
KLKefeng Lu
Kefeng Lu
XYXiushan Yin
Xiushan Yin
TWTujun Weng
Tujun Weng
SXShenli Xi
Shenli Xi
LLLi Li
Li Li
FHFuchu He
Fuchu He

30 April 2017 in Cancer Research
Verified
Journal Article
Open access
PDF file
KZKai Zhang
Kai Zhang
YGYanjing Guo
Yanjing Guo
XWXue Wang
Xue Wang
HZHuifang Zhao
Huifang Zhao
ZJZhongzhong Ji
Zhongzhong Ji
Wei-Qiang GaoWei-Qiang Gao
Wei-Qiang Gao
Cancer stem-like cells (CSC) drive cancer progression and recurrence. Self-renewal expansion of CSC is achieved through symmetric cell division, yet how external stimuli affect intracellular regulatory programs of CSC division modes and stemness remains obscure. Here, we report that the hTERThigh prostate cancer cells exhibit CSC properties, including a stem cell–associated gene expression signature, long-term tumor-propagating capacity and epithelial-to-mesenchymal transition. In promoting the self-renewal symmetric division of hTERThigh prostate cancer cells, WNT3a dramatically decreased the ratio of hTERThigh prostate cancer cells undergoing asymmetric division. Increased WNT/β-catenin signal activation was also detected in hTERThigh prostate cancer cells. hTERT-mediated CSC properties were at least partially dependent on β-catenin. These findings provide novel cellular and molecular mechanisms for the self-renewal of CSC orchestrated by tumor microenvironmental stimuli and intracellular signals. Cancer Res; 77(9); 2534–47. ©2017 AACR.

19 April 2009 in Nature Cell Biology
Verified
Journal Article
Closed access
CTCHunyan Tian
CHunyan Tian
GXGuichun Xing
Guichun Xing
PXPing Xie
Ping Xie
KLKefeng Lu
Kefeng Lu
JNJing Nie
Jing Nie
FHFuchu He
Fuchu He

8 May 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LLLi Li
Li Li
BDBinwei Deng
Binwei Deng
GXGuichun Xing
Guichun Xing
YTYan Teng
Yan Teng
CTChunyan Tian
Chunyan Tian
FHFuchu He
Fuchu He
The tumor suppressor p53 regulates cell cycle progression and apoptosis in response to various types of stress, whereas excess p53 activity creates unwanted effects. Tight regulation of p53 is essential for maintaining normal cell growth. p53-associated cellular protein-testes derived (PACT, also known as P2P-R, RBBP6) is a 250-kDa Ring finger-containing protein that can directly bind to p53. PACT is highly up-regulated in esophageal cancer and may be a promising target for immunotherapy. However, the physiological role of the PACT–p53 interaction remains largely unclear. Here, we demonstrate that the disruption of PACT in mice leads to early embryonic lethality before embryonic day 7.5 (E7.5), accompanied by an accumulation of p53 and widespread apoptosis. p53-null mutation partially rescues the lethality phenotype and prolonged survival to E11.5. Endogenous PACT can interact with Hdm2 and enhance Hdm2-mediated ubiquitination and degradation of p53 as a result of the increase of the p53–Hdm2 affinity. Consequently, PACT represses p53-dependent gene transcription. Knockdown of PACT significantly attenuates the p53–Hdm2 interaction, reduces p53 polyubiquitination, and enhances p53 accumulation, leading to both apoptosis and cell growth retardation. Taken together, our data demonstrate that the PACT–p53 interaction plays a critical role in embryonic development and tumorigenesis and identify PACT as a member of negative regulators of p53.

10 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMin Liu
Min Liu
TSTongyu Sun
Tongyu Sun
NLNi Li
Ni Li
JPJunjie Peng
Junjie Peng
DFDa Fu
Da Fu
Wei-Qiang GaoWei-Qiang Gao
Wei-Qiang Gao
Autophagy is a central component of integrated stress responses that influences many inflammatory diseases, including inflammatory bowel disease (IBD) and colorectal cancer (CRC). While the core machinery is known, the molecular basis of the epigenetic regulation of autophagy and its role in colon inflammation remain largely undefined. Here, we report that BRG1, an ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for the homeostatic maintenance of intestinal epithelial cells (IECs) to prevent the inflammation and tumorigenesis. BRG1 emerges as a key regulator that directly governs the transcription of Atg16l1, Ambra1, Atg7 and Wipi2, which are important for autophagosome biogenesis. Defective autophagy in BRG1-deficient IECs results in excess reactive oxygen species (ROS), which leads to the defects in barrier integrity. Together, our results establish that BRG1 may represent an autophagy checkpoint that is pathogenetically linked to colitis and is therefore likely a potential therapeutic target for disease intervention.